CTRN earnings analysis
What we found in CTRN's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The provided 10-Q extract covers Part II disclosures rather than the Part I financial statements and MD&A, so revenue, margins, EPS, segment results, balance-sheet changes, and cash-flow trends cannot be reliably assessed from the filing text supplied. Controls were deemed effective as of August 1, 2026, and market-risk disclosures were unchanged over the twenty-six weeks ended that date. The company made no repurchases in the second quarter, leaving $40.0 million under authorization, and reported no material changes to its previously disclosed risk factors.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Disclosure controls deemed effective
- Management concluded that disclosure controls and procedures were effective as of August 1, 2026, providing reasonable assurance over required Exchange Act reporting.
- Market-risk profile unchanged
- The company reported no material changes in market risk during the twenty-six weeks ended August 1, 2026, versus the prior 10-K disclosures.
- $40.0 million buyback authorization remains
- No shares were repurchased during the second quarter of 2026, while $40.0 million remained available under the stock repurchase authorization as of August 1, 2026.
- No material litigation identified
- The company stated that no legal proceedings pending or threatened are expected to have a material adverse effect on financial condition, results of operations, or liquidity.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- No share repurchases in Q2
- The company repurchased 0 shares in the second quarter of 2026 despite $40.0 million remaining under authorization as of August 1, 2026, indicating that the authorization did not provide a near-term capital-return catalyst during the quarter.
- No updated risk-factor disclosure
- The company states there were no material changes to the risk factors in the 10-K for the fiscal year ended January 31, 2026; therefore, this filing does not identify any newly quantified risk mitigants or exposures.
What they said about what is next.
The provided 10-Q extract contains no quantitative revenue, EPS, margin, or other operating guidance. It states that there were no material changes in market risk during the twenty-six weeks ended August 1, 2026.
The filing reads about the same as the one before it.
What came before.
- 10-Q · June 10, 2026
- Citi Trends reported a strong Q1 2026 with net sales of $230.9 million, reflecting a 14.4% increase year-over-year, driven by a 13.9% rise in comparable store sales. EPS of $1.08 significantly beat estimates, and gross…
- 10-K · April 15, 2026
- Citi Trends positions itself as the leading off-price retailer focused on Black customers, operating 590 stores in 33 states with an average selling space of approximately 11,000 square feet. The company highlights…
- 10-Q · December 10, 2025
- Citi Trends reported Q3 net sales of $197.1 million, up $18.0 million (+10.1% YoY) driven by a 10.8% comparable store sales increase; net loss narrowed to $6.9 million for the quarter. Gross margin compressed (cost of…
- 10-Q · June 12, 2024
- Citi Trends reported Q1 net sales of $186.3 million, up $6.6 million or 3.7% from $179.7 million a year ago, driven by a 3.1% comparable store sales increase. Gross margin improved (cost of sales down to 61.3% of sales)…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CTRN makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever